CHRISTOPHER GALBREATH: Open Payments
NPI 1235190521 · FAIRPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,963 in 141 payments from 11 companies in 2025. Trend: 2023 $2,665 · 2024 $2,247 · 2025 $2,963
Food & beverage: $2,963
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $615 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $614 |
| Vanda Pharmaceuticals Inc. | 19 | $395 |
| Otsuka America Pharmaceutical, Inc. | 11 | $284 |
| Axsome Therapeutics, Inc. | 10 | $233 |
| Teva Pharmaceuticals USA, Inc. | 11 | $224 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $190 |
| Supernus Pharmaceuticals, Inc. | 5 | $137 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| Alkermes, Inc. | 4 | $89 |
Products named: VRAYLAR, CAPLYTA, REXULTI, HETLIOZ, Auvelity, AUSTEDO XR, TRINTELLIX, Qelbree.
Industry payments across NY — which companies pay providers there.
